Facebook
X
LinkedIn
ForwardSubstance Use Disorders Management Boot Camp 2025 (September - November 2025)
Overview
This training aims to enhance confidence and competencies related to the management of substance use disorders in general medical settings. Through case-based and interactive didactic content, the workshop will explore issues related to assessment, monitoring, prevention, and management in the setting of unhealthy substance use.
Intended Audience
This program is designed for physicians, physician assistants, advanced practice nurses, nurses, pharmacists, social workers, students, residents, and fellows who treat patients with opioid use disorder.
Learning Objectives
As a result of participating in this activity, learners, as members of the healthcare team, will be able to:
- Determine accurate diagnosis and initiate treatment for opioid use disorder, alcohol withdrawal, and alcohol use disorder
- Demonstrate medical management and brief counseling skills needed to to work with patients who continue to use drugs and alcohol while in treatment for use disorder
- Determine appropriate treatment plan for OUD and AUD, including the initiation and maintenance of buprenorphine therapy, alcohol withdrawal management, and MAUD.
- Develop approaches to working with and managing patients with stimulant use disorders and/or Hepatitis C.
Elements of Competence
This educational activity is designed to change learner competence and focuses on the following competencies:
- Accreditation Council for Graduate Medical Education (ACGME)/Nursing: Patient care and procedural skills, medical knowledge, interpersonal and communication skills, and professionalism.
- National Academy of Medicine (NAM)/Nursing: Provide patient/person-centered care, employ evidence-based practice, population health
- Interprofessional Education Collaborative Competencies: Values/ethics for interprofessional practice, roles and responsibilities, communication, and teams and teamwork
- UW ICEP Diversity, Equity, and Inclusion: Engage in self-reflection and value diversity in the clinical encounter
Practice Gaps and Needs
Opioid use disorder can be challenging to treat in the primary care or office setting. The standards, methods and best practices in prescribing Medications for Opioid Use Disorder (MOUD), in particular Buprenorphine, change regularly and healthcare teams require up to date information on these practices. Providers lack a clear understanding in how to offer MOUD, and fail to comprehend how to interpret urine toxicology screens. Additionally, providers expressed interest in more education related to the logistical challenges commonly encountered when treating patients with complex opioid use disorders.
Planning Committee
| Randy Brown, MD, PhD, DFASAM, PROTEA Director, Professor in the Department of Family Medicine and Community Health, Director of the UW Center for Addictive Disorders, Program Director, UW Addiction Medicine Fellowship Programs |
| Kelly Eagen, MD, Assistant Professor, Department of Family Medicine and Community Health, Associate Program Director, Addiction Medicine Fellowship, UW-Madison School of Medicine and Public Health |
| James Eberhard, MFA, Accreditation Specialist, Office of Continuing Professional Development, UW-Madison School of Medicine and Public Health |
| David Leinweber, MD, MS, Assistant Professor, Department of Family Medicine and Community Health |
| Jill Lindwall, MSN, RN, CPHQ, Clinical Staff Educator at University of Wisconsin Medical Foundation |
| Kathleen Maher, Outreach Specialist, Department of Family Medicine and Community Health |
| Robert Redwood, MD, MPH, Emergency Physician at Absaroka Emergency Physicians, Bozeman, MT |
| Maggie Williams, MPAS, PA-C, CPAAPA, Addiction Medicine Physician Assistant, UW Health |
Faculty
| Randy Brown, MD, PhD, DFASAM, PROTEA Director, Professor in the Department of Family Medicine and Community Health, Director of the UW Center for Addictive Disorders, Program Director, UW Addiction Medicine Fellowship Programs |
| Kelly Eagen, MD, Assistant Professor, Department of Family Medicine and Community Health, Associate Program Director, Addiction Medicine Fellowship, UW-Madison School of Medicine and Public Health |
| David Leinweber, MD, MS, Assistant Professor, Department of Family Medicine and Community Health |
| Robert Redwood, MD, MPH, Emergency Physician at Absaroka Emergency Physicians, Bozeman, MT |
| Maggie Williams, MPAS, PA-C, CPAAPA, Addiction Medicine Physician Assistant, UW Health |
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below:
| Name | Role | Relevant Financial Relationships Disclosed | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
| Randy Brown MD, PhD, DFASAM | Clinical Director/Planning Committee Chair, Faculty | No relevant relationships with ineligible companies to disclose | No |
| Kelly Eagen, MD | Planning Committee Member, Faculty | No relevant relationships with ineligible companies to disclose | No |
| James Eberhard, MFA | Accreditation Specialist | No relevant relationships with ineligible companies to disclose | No |
| David Leinweber, MD, MS | Planning Committee Member, Faculty | No relevant relationships with ineligible companies to disclose | No |
| Jill Lindwall, MSN, RN, CPHQ | Planning Committee Member | ||
| Kathleen Maher | Activity Coordinator | No relevant relationships with ineligible companies to disclose | No |
| Robert Redwood, MD, MPH | Planning Committee Member, Faculty | No relevant relationships with ineligible companies to disclose | No |
| Maggie Williams, MPAS, PA-C, CPAAPA | Planning Committee Member, Faculty | No relevant relationships with ineligible companies to disclose | No |
| Accreditation Logos | Accreditation Statements |
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
Please see individual activities for CE credit details.
This activity is in-person only.
Questions about event, venue, or registration
Email Kathleen Maher [email protected]
Questions about claiming CE credit or help with ICEP Learning Portal
Email [email protected].
Program changes
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
Accessibility
We value inclusion and access for all participants and are pleased to provide reasonable accommodation for this event. Please contact [email protected] as soon as you can make a reasonable accommodation request.
For further information
For additional questions about the conference, including accessibility requests, please contact: Kathleen Maher [email protected].